Literature DB >> 16453017

C5a and Fcgamma receptors: a mutual admiration society.

John P Atkinson1.   

Abstract

Phagocytosis is a key process in protection of the host against pathogens and in provision of antigens for the immune response. Synergism between C3b and IgG and their receptors in promoting adherence to and then ingestion of an antigen has been recognized for decades. Only more recently, however, has cross-talk between another complement activation fragment, the anaphylatoxin C5a, and Fcgamma receptors (FcgammaRs) been defined. In this issue of the JCI, C5a is shown to signal, via its receptor, the upregulation of activating (proinflammatory-type) FcgammaRs. Moreover, engagement of FcgammaRs by the IgG-bearing immune complex instructs the cell to synthesize more C5, from which C5a is derived. Thus, this work establishes a feedback loop whereby FcgammaR expression and function are enhanced, a very desirable event in concert with an infection but potentially deleterious in autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16453017      PMCID: PMC1359066          DOI: 10.1172/JCI27759

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  7 in total

1.  A full complement of receptors in immune complex diseases.

Authors:  Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Authors:  Nelli Shushakova; Julia Skokowa; Jurriaan Schulman; Ulrich Baumann; Jörg Zwirner; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.

Authors:  Varsha Kumar; Syed R Ali; Stephanie Konrad; Jörg Zwirner; J Sjef Verbeek; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

Review 4.  Fc receptors and their interaction with complement in autoimmunity.

Authors:  Reinhold E Schmidt; J Engelbert Gessner
Journal:  Immunol Lett       Date:  2005-08-15       Impact factor: 3.685

5.  C5a initiates the inflammatory cascade in immune complex peritonitis.

Authors:  Jeanne Godau; Tanja Heller; Heiko Hawlisch; Matthew Trappe; Elaine Howells; Jennifer Best; Jörg Zwirner; J Sjef Verbeek; P Mark Hogarth; Craig Gerard; Nico Van Rooijen; Andreas Klos; J Engelbert Gessner; Jörg Köhl
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

6.  The effect of Bacillus Calmette-Guerin-induced macrophage activation on the in vivo clearance of sensitized erythrocytes.

Authors:  J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

7.  Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody.

Authors:  Samareh Azeredo da Silveira; Shuichi Kikuchi; Liliane Fossati-Jimack; Thomas Moll; Takashi Saito; J Sjef Verbeek; Marina Botto; Mark J Walport; Michael Carroll; Shozo Izui
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

  7 in total
  9 in total

1.  Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.

Authors:  Beatrix Schäfer; Adrian M Piliponsky; Tatsuya Oka; Chang Ho Song; Norma P Gerard; Craig Gerard; Mindy Tsai; Janet Kalesnikoff; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2012-06-22       Impact factor: 10.793

2.  Extravasations and emigration of neutrophils to the inflammatory site depend on the interaction of immune-complex with Fcgamma receptors and can be effectively blocked by decoy Fcgamma receptors.

Authors:  Rangaiah Shashidharamurthy; Randolph A Hennigar; Sebastien Fuchs; Purani Palaniswami; Melanie Sherman; Periasamy Selvaraj
Journal:  Blood       Date:  2007-10-25       Impact factor: 22.113

Review 3.  Molecular basis for downregulation of C5a-mediated inflammation by IgG1 immune complexes in allergy and asthma.

Authors:  Manoj Kumar Pandey
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

4.  Novel adenovirus vectors 'capsid-displaying' a human complement inhibitor.

Authors:  Sergey S Seregin; Zachary C Hartman; Daniel M Appledorn; Sarah Godbehere; Haixiang Jiang; Michael M Frank; Andrea Amalfitano
Journal:  J Innate Immun       Date:  2010-02-11       Impact factor: 7.349

5.  C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis.

Authors:  Huibin Qi; Erdem Tüzün; Windy Allman; Shamsher S Saini; Zurina R Penabad; Silvia Pierangeli; Premkumar Christadoss
Journal:  J Neuroimmunol       Date:  2008-05-01       Impact factor: 3.478

Review 6.  Targeting of G-protein coupled receptors in sepsis.

Authors:  Abdul Rehman; Noor Ul-Ain Baloch; John P Morrow; Pál Pacher; György Haskó
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

7.  TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis.

Authors:  Joanna Raszeja-Wyszomirska; Ewa Wunsch; Agnieszka Kempinska-Podhorodecka; Daniel S Smyk; Dimitrios P Bogdanos; Malgorzata Milkiewicz; Piotr Milkiewicz
Journal:  Clin Dev Immunol       Date:  2013-04-28

8.  Characteristics of spinal microglia in aged and obese mice: potential contributions to impaired sensory behavior.

Authors:  SeungHwan Lee; YaSi Wu; Xiang Qun Shi; Ji Zhang
Journal:  Immun Ageing       Date:  2015-11-24       Impact factor: 6.400

9.  Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin.

Authors:  Aline Dupont; Fatima Mohamed; Nur'Ain Salehen; Sarah Glenn; Lorenza Francescut; Rozita Adib; Simon Byrne; Hannah Brewin; Irina Elliott; Luke Richards; Petya Dimitrova; Wilhelm Schwaeble; Nina Ivanovska; Aras Kadioglu; Lee R Machado; Peter W Andrew; Cordula Stover
Journal:  Med Microbiol Immunol       Date:  2014-04-12       Impact factor: 3.402

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.